Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP

Cancer Research

Volumn 57, Issue 6, 1997, Pages 1086-1090

  Swinnen, Johannes V ^a   Esquenet, Murielle ^a   Goossens, Karine ^a   Heyns, Walter ^a   Verhoeven, Guido ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b LEGENDO   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BICALUTAMIDE; FATTY ACID SYNTHASE; METRIBOLONE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; FATTY ACID SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

ADENOCARCINOMA; ANDROGEN ANTAGONISTS; ANDROGENS; ANILIDES; DIHYDROTESTOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; FATTY ACID SYNTHETASE COMPLEX; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPIDS; MALE; METRIBOLONE; NANDROLONE; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TESTOSTERONE; TESTOSTERONE CONGENERS; TUMOR CELLS, CULTURED;

EID: 0030936232     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Horoszewicz, J. S., Leong, S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A., and Murphy, G. P. LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809-1818, 1983.
2. Swinnen, J. V., Van Veldhoven, P. P., Esquenet, M., Heyns, W., and Verhoeven, G. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. Endocrinology, 137: 4468-4474, 1996.
3. Semenkovich, C. F., Coleman, T., and Fiedorek, F. T., Jr. Human fatty acid synthase mRNA: tissue distribution, genetic mapping, and kinetics of decay after glucose deprivation. J. Lipid Res., 36: 1507-1521, 1995.
4. Jayakumar, A., Tai, M-H., Huang, W-Y., Al-Feel, W., Hsu, M., Abu-Elheiga, L., Chirala, S. S., and Wakil, S. J. Human fatty acid synthase: properties and molecular cloning. Proc. Natl. Acad. Sci. USA, 92: 8695-8699, 1995.
5. Kuhajda, F. P., Jenner, K., Wood, F. D., Hennigar, R. A., Jacobs, L. B., Dick, J. D., and Pasternack, G. R. Fatty acid synthase: a potential selective target for antineo-plastic therapy. Proc. Natl. Acad. Sci. USA, 91: 6379-6383, 1994.
6. Kuhajda, F. P., Piantadosi, S., and Pasternack, G. R. Haptoglobin-related epitopes in breast cancer as a predictor of recurrence of the disease. N. Engl. J. Med., 321: 636-641, 1989.
7. Corrigan, C., Martin, A. W., Lear, S. C., Kuhns, S., Kuhajda, F. P., and Pasternack, G. R. Prognostic value of the immunohistochemical demonstration of haptoglobin-related protein in breast cancer. Am. J. Clin. Pathol., 96: 406, 1991.
8. Shurbaji, M. S., Kuhajda, F. P., Pasternack, G. R., and Thurmond, T. S. Expression of oncogenic antigen 519 (OA-519) in prostate cancer is a potential prognostic indicator. Am. J. Clin Pathol., 97: 686-691, 1992.
9. Redston, M. S., Kern, S. E., Vogelstein, B., and Hamilton, S. R. Expression of OA519 (haptoglobin-related protein epitopes) in colorectal carcinomas: comparison with molecular genetic alterations and metastasis. Mod. Pathol., 5: 47A, 1992.
10. Jensen, V., Holm-Nielsen, P., and Melsen, F. OA-519 expression in node negative breast cancer. Breast Cancer Res. Treat., 27: 1-2, 1993.
11. Jensen, V., Ladekari, M., Holm-Nielsen, P., Flemming, B. S., and Flemming, M. The prognostic value of oncogenic antigen 519 (OA519) expression and proliferative activity detected by antibody MIB-1 in node negative breast cancer. J. Pathol., 176: 343-352, 1995.
12. Hardman, W., Gansler, T., Schaffel, S., and Henniger, R. OA-519 immunostaining portends poor prognosis in ovarian cancer. Mod. Pathol., 8: 90A, 1995.
13. Epstein, J. I., Carmichael, M., and Partin, A. W. OA-519 (fatty acid synthase) as an independent predictor of pathologic stage in adenocarcinoma of the prostate. Urology, 45: 81-86, 1995.
14. Alo, P. L., Visca, P., Marci, A., Mangoni, A., Botti, C., and Di Tondo, U. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer (Phila.), 77: 474-482, 1996.
15. Bobrow, L. G., Happerfield, L. C., Pasternack, G. R., Smith, P., and Owens, A. H. The expression of fatty acid synthase in primary breast cancer: is it an independent prognostic indicator? Breast Cancer Res. Treat., 27: 159, 1993.
16. Rashid, A., Milgraum, L. Z., Pasternack, G. R., Kuhajda, F. P., and Hamilton, S. R. Expression of fatty acid synthase in colorectal cancer. Mod. Pathol., 8: 67A, 1995.
17. Pizer, E. S., Wood, F. D., Pasternack, G. R., and Kuhajda, F. P. Altered fatty acid biosynthesis in endometrial carcinoma. Mod. Pathol., 8: 95A, 1995.
18. Chalbos, D., Escot, C., Joyeux, C., Tissot-Carayon, M-J., Pages, A., Rochefort, H. Expression of the progestin-induced fatty acid synthase in benign mastopathies and breast cancer as measured by RNA in situ hybridization. J. Natl. Cancer Inst., 82: 602-606, 1990.
19. Pizer, E. S., Wood, F. D., Pasternack, G. R., and Kuhajda, F. P. Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Res., 56: 745-751, 1996.
20. Pizer, E. S., Wood, F. D., Heine, H. S., Romantsev, F. E., Pasternack, G. R., and Kuhajda, F. P. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res., 56: 1189-1193, 1996.
21. Pizer, E. S., Jackisch, C., Wood, F. D., Pasternack, G. R., Davidson, N. E., and Kuhajda, F. P. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res., 56: 2745-2747, 1996.
22. Leake, R. E., Freshney, R. I., and Munir, I. Steroid response in vivo and in vitro. In: B. Green and R. E. Leake (eds.), Steroid Hormones: A Practical Approach, p. 214. Washington, DC: IRL Press, 1987.
23. Swinnen, J. V., Esquenet, M., Heyns, W., Rombauts, W., and Verhoeven, G. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acylCoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP. Mol. Cell. Endocrinol., 104: 153-162, 1994.
24. Adams, M. D., Dubnick, M., Kerlavage, A. R., Moreno, R., Kelley, J. M., Utterback, T. R., Nagle, J. W., Fields, C., and Venter, J. C. Sequence identification of 2,375 human brain genes. Nature (Lond.), 355: 632-634, 1992.
25. Verhoeven, G., Deboel, L., Swinnen, J., Rombauts, L, Vanderhoydonc, F., Rosseels, J., Hoeben, E., and Heyns, W. Effect of androgens on the germ cell-depleted testes of prenatally irradiated rats. Int. J. Androl., 18: 23-34, 1995.
26. Labarca, C., and Paigen, K. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem., 102: 344-352, 1980.
27. Riegman, P. H. J., Vlietstra, R. J., van der Korput, J. A. G. M., Brinkmann, A. O., and Trapman, J. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol. Endocrinol., 5: 1921-1930, 1991.
28. Young, C. Y-F., Montgomery, B. T., Andrews, P. E., Qiu, S., Bilhartz, D. L., and Tindall, D. J. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res., 51: 3748-3752, 1991.
29. Henttu, P., Liao, S., and Vihko, P. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA) but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology, 130: 766-772, 1992.
30. Wolf, D. A., Schulz, P., and Fittler, F. Transcriptional regulation of prostate kallikrein-like genes by androgen. Mol. Endocrinol., 6: 753-762, 1992.
31. Veldscholte, J., Berrevoets, C. A., Ris-Stalpers, C., Kuiper, G. G. J. M., Jenster, G., Trapman, J., Brinkmann, A. O., and Mulder, E. The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J. Steroid Biochem. Mol. Biol., 41: 665-669, 1992.
32. Esquenet, M., Swinnen, J. V., Heyns, W., and Verhoeven, G. Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1α,25-dihy-droxycholecalciferol. all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate. Prostate, 28: 182-194, 1996.
33. Chambon, M., Rochefort, H., Vial, H., and Chalbos, D. Progestins and androgens stimulate lipid accumulation in T47D breast cancer cells via their own receptor. J. Steroid Biochem., 33: 915-922, 1989.